The Food and Drug Administration on Nov. 19 recommended removing from the market propoxyphene, a painkiller commonly sold as Darvon and Darvocet.

On the same day, physician users of the free, Web-based and advertiser supported electronic health records system of Practice Fusion received an alert from the San Francisco-based vendor.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access